PriceSensitive

Bod Australia (ASX:BOD) awarded US Hemp Authority certificate for CBD extract

ASX News, Health Care
ASX:BOD      MCAP $4.256M
19 August 2022 13:00 (AEST)

This browser does not support the video element.

Bod Australia (BOD) has been awarded US Hemp Authority Certification for its exclusive CBD extract and related products sold under the CBII brand in the US.

The program is the hemp industry’s initiative to provide the highest standards, best practices and self-regulation to underpin consumer and retailer confidence in hemp and CBD products.

The process was undertaken over a 12-month period and included verification around the company’s CBD extract, stringent lab testing and ensuring operations do not utilise synthetic cannabinoids.

The certification adds to the company’s ongoing regulatory recognition, which includes the company’s UK novel food application and is generally recognised as safe status in line with the US Food and Drug Administration safety guidelines.

Further, Bod said certification provides another third-party endorsement for its products and adds another competitive advantage in the US.

The company sees this as another opportunity to increase brand recognition amongst key customers and provides Bod with another intellectual property asset to leverage and drive revenue streams.

CEO Jo Patterson said to have passed the testing process validates the “superior” quality of the company’s extract, operations and product development initiatives.

“Having been awarded the certification adds to the growing list of regulatory recognition for Bod’s extract which has already been validated in both the UK and the US,” she said.

“Further, we anticipate that the US Hemp Authority’s seal of approval will provide consumers with added confidence in the company’s products.”

Shares in Bod were up 4.17 per cent, trading at 10 cents at 12:58 pm AEST.

Related News